Mao Chen, Pinal Rodolfo, Morris Kenneth R
Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, Indiana 47907, USA.
Pharm Res. 2005 Jul;22(7):1149-57. doi: 10.1007/s11095-005-5363-8. Epub 2005 Jul 22.
The objective of the study is to develop a model to estimate the solubility ratio of two polymorphic forms based on the calculation of the free energy difference of two forms at any temperature. This model can be used for compounds with low solubility (a few mole percent) in which infinite dilution can be approximated.
The model is derived using the melting temperature and heat of fusion for apparent monotropic systems, and the solid-solid transition temperature and heat of transition for apparent enantiotropic systems. A rigorous derivation also requires heat capacity (Cp) measurement of liquid and two solid forms. This model is validated by collecting thermal properties of polymorphs for several drugs using conventional or modulated differential scanning calorimetry. From these properties the solubility ratio of two polymorphs is evaluated using the model and compared with the experimental value at different temperatures.
The predicted values using the full model agree well with the experimental ones. For the purpose of easy measurement, working equations without Cp terms are also applied. Ignoring Cp may result in an error of 10% or less, suggesting that the working equation is applicable in practice. Additional error may be generated for the apparent enantiotropic systems due to the inconsistency between the observed solid-solid transition temperature and the true thermodynamic transition temperature. This inconsistency allows the predicted solubility ratios (low melt/high melt) to be smaller. Therefore, a correction factor of 1.1 is recommended to reduce the error when the working equation is used to estimate the solubility ratio of an enantiotropic system.
The study of the free energy changes of two crystalline forms of a drug allows for the development of a model that successfully predicts the solubility ratio at any temperature from their thermal properties. This model provides a thermodynamic foundation as to how the free energy difference of two polymorphs is reflected by their equilibrium solubilities. It also provides a quick and practical way of evaluating the relative solubility of two polymorphs from single differential scanning calorimetry runs.
本研究的目的是开发一种模型,基于计算两种晶型在任何温度下的自由能差来估算其溶解度比。该模型可用于低溶解度(几摩尔百分比)的化合物,其中可近似无限稀释的情况。
该模型是利用表观单向系统的熔点和熔化热,以及表观双向系统的固-固转变温度和转变热推导得出的。严格的推导还需要测量液体和两种固体形式的热容(Cp)。通过使用常规或调制差示扫描量热法收集几种药物多晶型的热性质来验证该模型。根据这些性质,使用该模型评估两种多晶型的溶解度比,并与不同温度下的实验值进行比较。
使用完整模型的预测值与实验值吻合良好。为便于测量,还应用了不含Cp项的工作方程。忽略Cp可能导致10%或更小的误差,这表明该工作方程在实际中是适用的。对于表观双向系统,由于观察到的固-固转变温度与真实热力学转变温度之间的不一致,可能会产生额外误差。这种不一致使得预测的溶解度比(低熔点/高熔点)更小。因此,建议使用1.1的校正因子来减少使用工作方程估算双向系统溶解度比时的误差。
对药物两种晶型的自由能变化进行研究,有助于开发一种模型,该模型能根据热性质成功预测任何温度下的溶解度比。该模型为两种多晶型的自由能差如何通过其平衡溶解度反映提供了热力学基础。它还提供了一种从单次差示扫描量热法运行中快速实用地评估两种多晶型相对溶解度的方法。